Concepedia

Kathleen Myers

KM

11

Publications

881

Citations

11

H-Index

1992

Active since

Affiliations

Ionis Pharmaceuticals (United States)(Current)

Center for Neurologic Study

Rutgers, The State University of New Jersey

Harvard University

Barrow Neurological Institute

Kathleen Myers is an author at Ionis Pharmaceuticals (United States) specializing in medicine, immunology, and autoimmune disease.

Top concepts

Publications per year

1992–2018

11

Publications

11

Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis

Hong Zhang, Jesse D. Cook, Jeffrey C. Nickel et al. · Nature Biotechnology · 2000 · 271 citations

, , +18

Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis

Ethel J. Gordon, Kathleen Myers, Joseph P. Dougherty et al. · Journal of Neuroimmunology · 1995 · 116 citations

, , +11

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial

Richard Smith, Erik P. Pioro, Kathleen Myers et al. · Neurotherapeutics · 2017 · 104 citations · Full text

, , +16

Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-α in Two Murine Models of Colitis

Kathleen Myers, Sreekant Murthy, Anne Flanigan et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 90 citations

Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis

Kathleen Myers, Jonathan Sprent, Joseph P. Dougherty et al. · Journal of Neuroimmunology · 1992 · 85 citations

, , +12

Rows per page

1–5 of 11